Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Tessera... unsaid as well

Each of their patents have had a high % of claims rejected. 3 patents with 25 of 66 claims...23 of 29 claims and 14 of 29 claims rejected. Also trial now on hold.

I think our situation is far better, but it certainly should prove to everyone that, when in these situations, nomatter what exchange you're on or what management says or does, your stock is a very tough sell.

Share
New Message
Please login to post a reply